SCHEMBL13699787

SCHEMBL13699787

CCOc1cccc2c(NC(=O)c3ccc4c(c3)OCO4)c(C(N)=O)oc12

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 8/20 0.58
HSD17B10 Q99714 6/20 0.58
KDM4E B2RXH2 5/20 0.58
TSHR P16473 3/20 0.58
CYP1A2 P05177 3/20 0.58
CYP3A4 P08684 3/20 0.58
CYP2C19 P33261 2/20 0.58
CYP2D6 P10635 1/20 0.58
MEN1 O00255 8/20 0.51
KMT2A Q03164 8/20 0.51
MAPT P10636 7/20 0.51
ALDH1A1 P00352 5/20 0.51
TP53 P04637 3/20 0.51
CYP2C9 P11712 1/20 0.51
LMNA P02545 3/20 0.51
ALOX15 P16050 1/20 0.51
MAPK10 P53779 1/20 0.51
USP2 O75604 3/20 0.49
RAB9A P51151 6/20 0.48
NPC1 O15118 5/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13699726 0.84 MAPT (0.53) HPGDHSD17B10KDM4ETSHRCYP3A4
SCHEMBL13699889 0.83 TP53 (0.60) HPGDHSD17B10KDM4ETSHRCYP1A2
SCHEMBL13699704 0.83 MAPT (0.60) HPGDHSD17B10TSHRMEN1KMT2A
SCHEMBL13699884 0.83 MAPT (0.52) HPGDHSD17B10KDM4ETSHRMEN1
SCHEMBL13699868 0.82 MAPT (0.59) HPGDHSD17B10KDM4ETSHRCYP1A2
SCHEMBL13699763 0.82 HPGD (0.67) HPGDHSD17B10KDM4ETSHRCYP1A2
SCHEMBL13699746 0.81 MAPT (0.50) HPGDHSD17B10KDM4ETSHRCYP1A2
SCHEMBL13699973 0.80 MEN1 (0.56) HPGDHSD17B10KDM4ETSHRMEN1
SCHEMBL13699966 0.80 MAPT (0.64) HPGDHSD17B10KDM4ETSHRMEN1
SCHEMBL13699766 0.79 TSHR (0.52) HPGDHSD17B10KDM4ETSHRCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-09-24 US disclosed
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-09-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE ADORA2A, ADORA2B, HTR1F HPGD 3251/4885HSD17B10 1250/4885KDM4E 4227/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.